Opendata, web and dolomites

CANCERSCREEN SIGNED

Screening for cancer in the post-genomic era: diagnostic innovation and biomedicalisation in comparative perspective

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CANCERSCREEN project word cloud

Explore the words cloud of the CANCERSCREEN project. It provides you a very rough idea of what is the project "CANCERSCREEN" about.

alia    regime    regulation    sickness    scientometric    theory    decision    domain    redrawing    decade    shaping    platform    investments    genome    dynamics    disease    actors    harms    continue    screening    diagnostic    revolution    opinion    policy    integration    tests    combining    quantitative    unprecedented    gene    interactions    monopolies    usa    socio    technological    public    inter    biomedicine    expectations    day    linking    data    fuel    paucity    regulatory    boundaries    risks    examine    industry    map    expert    genomic    surrounding    cancer    deliberation    reconfiguring    technologies    age    innovative    model    literature    diagnostics    transition    biomedicalisation    steer    molecular    freight    trajectories    conceptual    categories    accompanied    dimensions    health    generation    human    innovation    anecdote    scholarship    economy    empirical    qualitative    transnational    patenting    political    detection    first    private    insights    1996    integrative   

Project "CANCERSCREEN" data sheet

The following table provides information about the project.

Coordinator
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE 

Organization address
address: TRINITY LANE THE OLD SCHOOLS
city: CAMBRIDGE
postcode: CB2 1TN
website: www.cam.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 1˙347˙992 €
 EC max contribution 1˙347˙992 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) coordinator 1˙047˙674.00
2    THE UNIVERSITY OF SUSSEX UK (BRIGHTON) participant 300˙317.00

Map

 Project objective

Cancer screening and the diagnostics industry: a comparative analysis of the political economy of diagnostic innovation A decade after the Human Genome Project, major public and private investments continue to fuel expectations of a genomic revolution in biomedicine. The freight of expectations surrounding the new “age of diagnostics” is accompanied by much uncertainty about how public policy should steer diagnostic innovation, with much debate about inter alia the harms of creating diagnostic monopolies through gene patenting, and the risks of under- or over-regulation. However, due to the paucity of research on diagnostic innovation, policy deliberation is driven more by anecdote and expert opinion than empirical evidence. With a specific focus on screening/early detection of cancer, this project will map industry dynamics, technological trajectories and regulatory developments in Europe and the USA from 1996 to the present day. Combining quantitative and qualitative methods, the project’s innovative dimensions include a new conceptual model of socio-technical transition in the diagnostics sector, and the first integrative analysis linking scientometric data on the interactions between public and private actors in the diagnostic research domain with comparative transnational analysis of regulatory decision-making. Through a novel integration of conceptual insights from the literature on biomedicalisation and scholarship on socio-technical regime change, this project aims to advance both fields of research by applying a new multi-scale, multi-level model of socio-technical transition. The project will provide unprecedented insight into the factors shaping the development of a new generation of molecular diagnostic tests, and examine how these technologies are reconfiguring disease categories and redrawing the boundaries between health and sickness. We will establish a platform of theory and methods for a broader programme of work on diagnostic innovation.

 Publications

year authors and title journal last update
List of publications.
2019 Kelly Holloway, Fiona A Miller, Alberto Gutierrez, Stuart Hogarth
Dangerous diagnostics? Regulatory reform in the genomic era
published pages: l640, ISSN: 0959-8138, DOI: 10.1136/bmj.l640
BMJ 2020-01-30
2019 Kelly Holloway, Fiona A. Miller, François Rousseau, Alberto Gutierrez, Stuart Hogarth
Health Canada needs to act on laboratory-developed diagnostics
published pages: E1067-E1069, ISSN: 0820-3946, DOI: 10.1503/cmaj.190550
Canadian Medical Association Journal 191/39 2020-01-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCERSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CANCERSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ERC VP CSA (2018)

Support to the Vice-Presidents of the ERC Scientific Council 2018

Read More  

CELPRED (2020)

Circuit elements of the cortical circuit for predictive processing

Read More  

CellProbe (2019)

CellProbe: Microfluidic probe for simultaneous tagging and extraction of single cells

Read More